PHILADELPHIA, April 8, 2021 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, announced today expanded electronic informed consent offerings and enhanced ...

PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced ...

PHILADELPHIA, June 29, 2021 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, today announced a new acceleration program that reduces study setup timelines ...

PHILADELPHIA, Dec. 11, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Krishna Maridi as chief financial officer.

Signant Health is ramping up its virtual trial model after buying VirTrial to “truly digitize the operations of clinical study sites.” Signant Health, like so many others trying to navigate the ...

PHILADELPHIA, Oct. 30, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, today announced a strategic alignment with SPRIM PRO, a boutique contract ...

Signant Health, which is backed by Genstar Capital, has appointed Roger Smith as CEO. Previously, Smith worked at PPD where he was senior vice president and general manager of Accelerated Enrollment ...

Signant Health acquired fellow trial data specialist DSG for an undisclosed price as part of its plans to expand service offerings for site-based and decentralized clinical studies.

PHILADELPHIA, May 8, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today that it has substantially reduced implementation timelines for ...

The research approach will help small- to mid-sized organisations to advance their clinical studies The research approach will help small- to mid-sized organisations to advance their clinical studies ...